Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, China
Dr. Lijian Hui obtained his PhD degree from Shanghai Institute of Biochemistry and Cell Biology (SIBCB) and had Postdoc training at Institute of Molecular Pathology, Vienna. Dr. Hui was among the first to characterize the in vivo functions of p38 and JNK MAP kinases in liver tumorigenesis. After moving back to SIBCB at 2008, Dr. Hui focuses on understanding cell identity conversion in liver regeneration and tumorigenesis. His lab was the first to show the generation of functional hepatocytes (hiHeps) from cells of non-hepatic origin and the application of hiHeps in bio-artificial device for liver failure treatment.